Personnel Changes

TOKYO, February 3, 2022 --Chugai Pharmaceutical Co., Ltd.(TOKYO: 4519) announced the following personnel changes, effective March 29 and April 1, 2022 respectively.

[Details of Personnel Changes]

Effective, March 29, 2022

Directors

Name

New Responsibilities

Current Responsibilities

Osamu Okuda

Representative Director, President

Representative Director, President

Chief Executive Officer (CEO)

Chief Executive Officer (CEO)

Supervisory responsibility for

Supervisory responsibility for

Corporate Planning, Partnering,

Clinical Development,

External Affairs and Audit

Pharmaceutical Technology, Drug

In charge of Corporate Planning

Safety, Medical Affairs, Marketing &

Dept., External Affairs Dept., and

Sales and Foundation Medicine

Audit Dept.

Hisafumi Yamada

Director, Executive Vice President

Executive Vice President

Supervisory responsibility for

Supervisory responsibility for

Project & Lifecycle Management

Project & Lifecycle Management

(R&D), Research, Translational

(R&D), Research and Translational

Research, Clinical Development

Research

and Pharmaceutical Technology

Toshiaki Itagaki

Director, Executive Vice President

Executive Vice President

Chief Financial Officer (CFO)

Chief Financial Officer (CFO)

Supervisory responsibility for

Supervisory responsibility for

Finance & Accounting, Corporate

Finance & Accounting, Corporate

Communication and Purchasing

Communication, Purchasing and

Head of Finance Supervisory Div.

Digital Transformation

Head of Finance Supervisory Div.

  • The appointment of Osamu Okuda as Chairman of the Board of Directors is subject to approval at the Board of Directors Meeting, which is scheduled to be convened on March 29, 2022
  • The appointment of Hisafumi Yamada and Toshiaki Itagaki as Directors is subject to approval at the 111th Annual General Meeting of Shareholders, which is scheduled to be convened on March 29, 2022.
  • Tatsuro Kosaka is scheduled to retire from Representative Director, Chairman as of March 29, 2022 to be appointed as Senior Advisor.
  • Motoo Ueno is scheduled to retire from Representative Director, Deputy Chairman as of March 29, 2022 to be appointed as Senior Advisor.

Executive Officers

Name

New Responsibilities

Current Responsibilities

Shinya Unno

Deputy President

Deputy President

Special Mission for CEO

Supervisory responsibility for

Human Resources Management,

Legal, Intellectual Property and

General Affairs

In charge of General Affairs Dept.

Tetsuya

Executive Vice President

Executive Vice President

Yamaguchi

Supervisory responsibility for

Supervisory responsibility for

Project & Lifecycle Management

Project & Lifecycle Management

(Marketing), Drug Safety, Medical

(Marketing), Corporate Planning,

Affairs and Foundation Medicine

Quality & Regulatory Compliance

Head of Project & Lifecycle

Head of Project & Lifecycle

Management Unit

Management Unit

In charge of Corporate Planning

Dept.

Junichi Ebihara

Senior Vice President

Senior Vice President

Supervisory responsibility for Legal,

In charge of Legal Dept. and

Intellectual Property, General

Intellectual Property Dept.

Affairs, Risk Management,

Compliance, and Quality &

Regulatory Compliance

In charge of Legal Dept.,

Intellectual Property Dept., and

General Affairs Dept.

Shinji Hidaka

Vice President

Vice President

Supervisory responsibility for

Head of Marketing & Sales Div.

Marketing & Sales

Head of Marketing & Sales Div.

Yoshiyuki Yano

Vice President

Vice President

Supervisory responsibility for

Head of Human Resources

Human Resource Management and

Management Dept.

EHS

Head of Human Resources

Management Dept.

In charge of Sustainability Dept.

Satoko Shisai

Vice President

Vice President

Supervisory responsibility for Digital

Head of Digital Transformation Unit

Transformation

Head of Digital Transformation Unit

2 / 3

Effective April 1, 2022

Executive Officers

Name

New Responsibilities

Current Responsibilities

Shinji Hidaka

Executive Vice President

Vice President

Supervisory responsibility for

Supervisory responsibility for

Marketing & Sales

Marketing & Sales

Head of Marketing & Sales Div.

Head of Marketing & Sales Div.

Yoshiyuki Yano

Executive Vice President

Vice President

Supervisory responsibility for

Supervisory responsibility for

Human Resource Management and

Human Resource Management and

EHS

EHS

Head of Human Resources

Head of Human Resources

Management Dept.

Management Dept.

In charge of Sustainability Dept.

In charge of Sustainability Dept.

Satoko Shisai

Executive Vice President

Vice President

Supervisory responsibility for Digital

Supervisory responsibility for Digital

Transformation

Transformation

Head of Digital Transformation Unit

Head of Digital Transformation Unit

Hitoshi Iikura

Vice President

Head of Research Div.

Head of Research Div.

Masayoshi

Vice President

Head of Quality & Regulatory

Higuchi

Head of Quality & Regulatory

Compliance Unit

Compliance Unit

  • Shinya Unno and Hiroyuki Matsumoto are scheduled to retire from Executive Officers as of March 31, 2022.

###

3 / 3

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Chugai Pharmaceutical Co. Ltd. published this content on 03 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 February 2022 08:08:05 UTC.